Aranding, Baby Boy .
HRN: 21-99-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/26/2022
11/02/2022
IVTT
47mg
Q24h
PSNB (Maternal UTI)
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes